Determining the mechanism of how GATA4 directs ERalpha binding in osteoblasts
确定 GATA4 如何指导成骨细胞中 ERα 结合的机制
基本信息
- 批准号:9101991
- 负责人:
- 金额:$ 33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-18 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAdipocytesAffectAgeAmericanAntibodiesBindingBinding ProteinsBinding SitesBiological AssayBiologyBone DensityBone DevelopmentBone Mineralization Regulation PathwayBrainChIP-seqChromatinDNADNA BindingDeoxyribonucleasesDependenceDiseaseEnhancersEstradiolEstrogen Receptor alphaEstrogensEventFemaleGATA4 geneGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionGoalsHairHealthHeterochromatinHistonesHomeostasisIn VitroKnock-outLiverLoxP-flanked alleleMaintenanceMammary Gland ParenchymaMesenchymal Stem CellsMolecularMusMutagenesisOsteoblastsOsteocalcinOsteoporosisOsteoporosis preventionOutcomePhysiologic calcificationPlayPostmenopausal OsteoporosisPostmenopauseProteinsRecruitment ActivityReporter GenesRoleSiteSkinSpecificityTechnologyTestingTimeTissuesUnited StatesWomanWorkbonebone cellbone masscell typechromatin immunoprecipitationchromatin remodelingexperiencegenome sequencinggenome-widehistone modificationin vivoinsightmalignant breast neoplasmmineralizationnovelosteoblast differentiationosteoporosis with pathological fracturepreventprogenitorpromoterrecombinasereproductive organresearch studyresponseskeletaltranscription factorwhole genome
项目摘要
DESCRIPTION (provided by applicant): Estrogens are important for the maintenance of bone mineral density and the prevention of osteoporosis (or low bone mass), a disease that affects more than 29.5 million people in the United States. Estrogen receptor alpha (ER�), in response to estrogens, increases bone mineral density by increasing osteoblast proliferation and differentiation. GATA4, as a pioneer factor (a protein that can bind to target DNA within silent chromatin and initiate chromatin remodeling and helps recruit other transcription factors to the same locus), helps determine these tissue-specific effects of ER� gene regulation in osteoblasts. However, when and where GATA4 binds to DNA, and how GATA4 directs ER� binding to enhancers to regulate osteoblast differentiation is currently unknown. The central hypothesis of this proposal is that GATA4 increases differentiation of mesenchymal stem cells (MSCs) to osteoblasts by opening chromatin for ER� binding to enhancers. This hypothesis will be tested with the following three specific aims. Aim 1 will determine when during differentiation ER� and GATA4 are necessary to regulate osteoblast differentiation using temporally regulated gene expression in vitro and in vivo. Aim 2 will identify where ER� and GATA4 bind to DNA to regulate osteoblast differentiation using state-of-the-art high throughput, whole-genome sequencing technology. Aim 3 will elucidate the mechanism by which GATA4 regulates ER� binding to osteoblast enhancers. Together these experiments will for the first time describe how the novel osteoblast transcription factor GATA4 regulates estrogen biology in bone. These results will have valuable impact through characterization of ER� tissue-specificity in bone and hence will further understanding of how estrogens prevent osteoporosis.
描述(由申请人提供):雌激素对于维持骨矿物质密度和预防骨质疏松症(或低骨量)非常重要,这种疾病影响着超过 2950 万美国人口。雌激素受体 α (ER�) 对雌激素作出反应,通过增加成骨细胞增殖和分化来增加骨矿物质密度。 GATA4 作为先锋因子(一种可以与沉默染色质内的目标 DNA 结合并启动染色质重塑并帮助将其他转录因子招募到同一位点的蛋白质),有助于确定 ER� 基因调控在成骨细胞中的这些组织特异性效应。然而,GATA4 何时何地与 DNA 结合,以及 GATA4 如何指导 ER� 与增强子结合以调节成骨细胞分化目前尚不清楚。该提议的中心假设是,GATA4 通过打开染色质使 ER� 与增强子结合来增加间充质干细胞 (MSC) 向成骨细胞的分化。该假设将通过以下三个具体目标进行检验。目标 1 将确定在分化过程中何时需要 ERβ 和 GATA4 使用体外和体内临时调节的基因表达来调节成骨细胞分化。目标 2 将利用最先进的高通量全基因组测序技术来确定 ER® 和 GATA4 与 DNA 结合的位置,以调节成骨细胞分化。目标 3 将阐明 GATA4 调节 ER� 与成骨细胞增强剂结合的机制。这些实验将首次描述新型成骨细胞转录因子 GATA4 如何调节骨骼中的雌激素生物学。这些结果将通过表征骨中 ER� 组织特异性产生有价值的影响,从而进一步了解雌激素如何预防骨质疏松症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan A Miranda其他文献
Susan A Miranda的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan A Miranda', 18)}}的其他基金
Determining the mechanism of how GATA4 directs ERalpha binding in osteoblasts
确定 GATA4 如何指导成骨细胞中 ERα 结合的机制
- 批准号:
8630906 - 财政年份:2014
- 资助金额:
$ 33万 - 项目类别:
Determining the mechanism of how GATA4 directs ERalpha binding in osteoblasts
确定 GATA4 如何指导成骨细胞中 ERα 结合的机制
- 批准号:
8913890 - 财政年份:2014
- 资助金额:
$ 33万 - 项目类别:
The role of WNT10B and HMGA2 in Lung Metastasis in Triple Negative Breast Cancer
WNT10B和HMGA2在三阴性乳腺癌肺转移中的作用
- 批准号:
8702123 - 财政年份:2013
- 资助金额:
$ 33万 - 项目类别:
The role of WNT10B and HMGA2 in Lung Metastasis in Triple Negative Breast Cancer
WNT10B 和 HMGA2 在三阴性乳腺癌肺转移中的作用
- 批准号:
8585768 - 财政年份:2013
- 资助金额:
$ 33万 - 项目类别:
Regulation of Estrogen Receptor Target Genes by the Pioneer Factor GATA4 in Bone
骨中先锋因子 GATA4 对雌激素受体靶基因的调节
- 批准号:
8145771 - 财政年份:2010
- 资助金额:
$ 33万 - 项目类别:
相似国自然基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
- 批准号:81970721
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
- 批准号:
23K16058 - 财政年份:2023
- 资助金额:
$ 33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
- 批准号:
23K10969 - 财政年份:2023
- 资助金额:
$ 33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
- 批准号:
10751284 - 财政年份:2023
- 资助金额:
$ 33万 - 项目类别:
Development of adipocytes for gene therapy that avoids cellular stress due to overexpression of therapeutic proteins
开发用于基因治疗的脂肪细胞,避免因治疗蛋白过度表达而造成的细胞应激
- 批准号:
23H03065 - 财政年份:2023
- 资助金额:
$ 33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analysis of bitter taste receptors in adipocytes and hepatocytes
脂肪细胞和肝细胞中苦味受体的功能分析
- 批准号:
23K05107 - 财政年份:2023
- 资助金额:
$ 33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of mechanisms for conversion of adipocytes to cancer-associated fibroblasts in osteosarcoma microenvironment
阐明骨肉瘤微环境中脂肪细胞转化为癌症相关成纤维细胞的机制
- 批准号:
23K19518 - 财政年份:2023
- 资助金额:
$ 33万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Study on UCP-1 independent metabolic regulation by brown adipocytes
棕色脂肪细胞对UCP-1独立代谢调节的研究
- 批准号:
23K18303 - 财政年份:2023
- 资助金额:
$ 33万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis
脂肪细胞中的 NKA/CD36 信号传导促进氧化应激并驱动动脉粥样硬化的慢性炎症
- 批准号:
10655793 - 财政年份:2023
- 资助金额:
$ 33万 - 项目类别:
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
- 批准号:
23K05594 - 财政年份:2023
- 资助金额:
$ 33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterizing breast cancer invasion and proliferation when co-aggregated with adipocytes in multicellular spheroids created with a custom bioreactor to augment cell-cell connectivity.
当与多细胞球体中的脂肪细胞共聚集时,表征乳腺癌的侵袭和增殖,该多细胞球体是用定制生物反应器创建的,以增强细胞间的连接。
- 批准号:
10334113 - 财政年份:2022
- 资助金额:
$ 33万 - 项目类别: